ACTOnco, ACTOnco IVD— 510(k) K210017

Substantially Equivalent

Act Genomics

FDA 510(k) clearance K210017 for ACTOnco, ACTOnco IVD, Substantially Equivalent on 2022-12-23. Applicant: Act Genomics.

Clearance details

Applicant: Act Genomics
Product code: Code PZM
Advisory panel: Pathology
Date received: 2021-01-04
Decision date: 2022-12-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Taipei, TW

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.